因covid-19导致中度低氧血症患者的俯卧位通气:多中心实用性随机试验(COVID-PRONE)
COVID-PRONE是一项在加拿大和美国15家医院开展的多中心实用性随机试验,纳入257例因covid-19住院、需要补充氧气(最高50%吸入氧浓度)的非危重患者,随机分为俯卧位通气组和标准治疗组。主要复合结局(院内死亡、机械通气或呼吸衰竭恶化)在俯卧位组18例(14%)与标准治疗组17例(14%)间相似(比值比0.92,95%置信区间0.44至1.92),试验因无效而提前终止,但置信区间较宽,无法排除获益或危害,且俯卧位依从性差。
要点
- 在非危重covid-19低氧血症患者中,增加俯卧位通气的多层面干预未改善结局。
- 主要结局风险俯卧位组18例(14%)与标准治疗组17例(14%)相似,比值比0.92(95%置信区间0.44至1.92)。
- 俯卧位依从性差,尽管采取了多种措施提高依从性。
核心结论
- 在因covid-19住院的非危重低氧血症患者中,增加俯卧位通气的多层面干预未改善结局。
- 但置信区间较宽,无法 definitively 排除获益或危害。
- 俯卧位依从性差,尽管采取了多种措施提高依从性。
研究设计与样本
- 多中心实用性随机临床试验,在加拿大和美国的15家医院开展,时间为2020年5月至2021年5月。
- 纳入标准为实验室确诊或临床高度怀疑covid-19、需要补充氧气(最高50%吸入氧浓度)且能独立在口头指令下俯卧的患者。
- 评估570例患者资格,257例随机,248例纳入分析;按1:1随机分为俯卧位通气组或标准治疗组。
主要发现
- 试验基于预设主要结局的无效性而提前终止。
- 从入院至随机化的中位时间为1天,患者中位年龄56岁(四分位距45-65),89例(36%)为女性,222例(90%)在随机化时经鼻导管吸氧。
- 前72小时内俯卧总时间中位数:俯卧位组6小时(1.5-12.8),标准治疗组0小时(0-2)。
- 主要结局风险:俯卧位组18例事件(14%),标准治疗组17例事件(14%),比值比0.92(95%置信区间0.44至1.92)。
- 随机分配至俯卧位通气与标准治疗的患者在72小时后氧饱和度与吸入氧浓度比值的变化相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 试验因预设主要结局的无效性而提前终止。
- 置信区间较宽,无法 definitively 排除获益或危害。
- 尽管采取多种措施提高依从性,俯卧位依从性仍差。
- 作者认为后续俯卧位通气试验应致力于开发提高清醒俯卧位依从性的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the effectiveness of prone positioning to reduce the risk of death or respiratory failure in non-critically ill patients admitted to hospital with covid-19. DESIGN: Multicentre pragmatic randomised clinical trial. SETTING: 15 hospitals in Canada and the United States from May 2020 until May 2021. PARTICIPANTS: Eligible patients had a laboratory confirmed or a clinically highly suspected diagnosis of covid-19, needed supplemental oxygen (up to 50% fraction of inspired oxygen), and were able to independently lie prone with verbal instruction. Of the 570 patients who were assessed for eligibility, 257 were randomised and 248 were included in the analysis. INTERVENTION: Patients were randomised 1:1 to prone positioning (that is, instructing a patient to lie on their stomach while they are in bed) or standard of care (that is, no instruction to adopt prone position). MAIN OUTCOME MEASURES: The primary outcome was a composite of in-hospital death, mechanical ventilation, or worsening respiratory failure defined as needing at least 60% fraction of inspired oxygen for at least 24 hours. Secondary outcomes included the change in the ratio of oxygen saturation to fraction of inspired oxygen. RESULTS: The trial was stopped early on the basis of futility for the pre-specified primary outcome. The median time from hospital admission until randomisation was 1 day, the median age of patients was 56 (interquartile range 45-65) years, 89 (36%) patients were female, and 222 (90%) were receiving oxygen via nasal prongs at the time of randomisation. The median time spent prone in the first 72 hours was 6 (1.5-12.8) hours in total for the prone arm compared with 0 (0-2) hours in the control arm. The risk of the primary outcome was similar between the prone group (18 (14%) events) and the standard care group (17 (14%) events) (odds ratio 0.92, 95% confidence interval 0.44 to 1.92). The change in the ratio of oxygen saturation to fraction of inspired oxygen after 72 hours was similar for patients randomised to prone positioning and standard of care. CONCLUSION: Among non-critically ill patients with hypoxaemia who were admitted to hospital with covid-19, a multifaceted intervention to increase prone positioning did not improve outcomes. However, wide confidence intervals preclude definitively ruling out benefit or harm. Adherence to prone positioning was poor, despite multiple efforts to increase it. Subsequent trials of prone positioning should aim to develop strategies to improve adherence to awake prone positioning. STUDY REGISTRATION: ClinicalTrials.gov NCT04383613.
引用
- Fralick M, Colacci M, Munshi L, et al. Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE). BMJ. 2022. PMID: 35321918. doi:10.1136/bmj-2021-068585
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。